Overview and Treatment of Guillain-Barré Syndrome (GBS)
PDF | 651 KB
  • GBS

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

GBS and Zika Virus
PDF | 856 KB
  • GBS
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
PDF | 2.2 MB
  • CIDP
  • GBS
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
IgG Levels and Wear Off Reflect Administration and Outcome
PDF | 1.5 MB
  • CIDP
  • GBS
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Incidence of GBS and CIDP Following Influenza Vaccination
PDF | 155 KB
  • CIDP
  • GBS

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
PDF | 680 KB
  • CIDP
  • GBS
  • MMN

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

PDF
Overview and Treatment of Guillain-Barré Syndrome (GBS)

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

PDF
GBS and Zika Virus
Understand the latest information on the Zika Virus and its relationship to Guillain-Barre´ syndrome
PDF
Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical Presentations
Learn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
PDF
IgG Levels and Wear Off Reflect Administration and Outcome
Learn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IV- or SCIg-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
PDF
Incidence of GBS and CIDP Following Influenza Vaccination

Gain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.

PDF
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies

Find out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.

Back to Top